Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Recruiting now · Phase 2

Conditions studied: Neuroblastoma

In brief

A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.

Key facts

Study ID
NCT02559778
Run by
Giselle Sholler
People needed
500
Starts
2015-09-01
Expected to finish
2035-09-01
Last updated by the study team
2026-04-28

Who can join

Age: any, up to 22. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.